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Background
HIV treatment in Mali is constrained by limited access
to HIV experts. In 2009, GAIA Vaccine Foundation’s
“Hope Center Clinic” (HCC), a community health center
in Mékin-Sikoro, became one of the first “front-line”
clinics to offer HIV treatment in Mali. To assess our
HIV prevention strategies and prepare for an eventual
HIV vaccine trial, we performed a retrospective study of
ten clinical parameters in patient charts.
Methods
The charts of 54 patients receiving antiretroviral therapy
(ART) at HCC between 04/2009-09/2011 (30 months)
were reviewed. Information on the presence of opportu-
nistic infections (OIs), weight changes, CD4 counts,
BMI, viral load (VL), CD4 T-cell counts, hemoglobin
(Hb), alanine aminotransferase, leukocyte counts, and
platelet counts were tabulated and analyzed in Excel.
Results
The mean age of the subjects in the study was 33; 85%
were women, of whom 57% received mother-to-child
transmission prevention at HCC. 93% had HIV-1; 33%
were WHO Stage I, 11% Stage 2, 24% Stage 3, and 4%
Stage 4. 48 (89%) patients improved in at least one para-
meter. 35 (65%) patients gained weight. 28 (70%)
patients had increased CD4 counts (74% of patients had
two counts recorded). 13 (59%) patients had decreased
VL (41% of patients had two VL recorded). OIs were
common among subjects (61%) prior to clinical inter-
vention, but decreased significantly by months 7-15 to
affect only 17% of subjects.
Conclusion
These data affirm that village-level HIV care is both fea-
sible and associated with positive patient outcomes.
Providing care allowed GAIA VF to reinforce the rap-
port between clinic staff and community members and
assess clinical interventions for HIV-positive patients.
Importantly, this develops strategies for treatment distri-
bution and adherence monitoring, patient follow-up and
retention, and study implementation and analysis that
lay the groundwork for the development of a Phase I-III
HIV vaccine trial site in this region of Mali.
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